Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Inventory: 2020-2025

Historic Inventory for Biofrontera (BFRI) over the last 4 years, with Sep 2025 value amounting to $4.3 million.

  • Biofrontera's Inventory fell 33.67% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year decrease of 33.67%. This contributed to the annual value of $6.6 million for FY2024, which is 39.07% down from last year.
  • As of Q3 2025, Biofrontera's Inventory stood at $4.3 million, which was up 7.47% from $4.0 million recorded in Q2 2025.
  • Biofrontera's 5-year Inventory high stood at $16.1 million for Q3 2023, and its period low was $3.9 million during Q2 2024.
  • Its 3-year average for Inventory is $7.3 million, with a median of $6.6 million in 2024.
  • Its Inventory has fluctuated over the past 5 years, first soared by 122.23% in 2022, then tumbled by 59.39% in 2024.
  • Over the past 5 years, Biofrontera's Inventory (Quarterly) stood at $4.5 million in 2021, then spiked by 60.79% to $7.2 million in 2022, then skyrocketed by 52.18% to $10.9 million in 2023, then tumbled by 39.07% to $6.6 million in 2024, then slumped by 33.67% to $4.3 million in 2025.
  • Its Inventory was $4.3 million in Q3 2025, compared to $4.0 million in Q2 2025 and $6.5 million in Q1 2025.